嗜水气单胞菌TPS-30株丝氨酸蛋白酶基因与溶血素基因在大肠杆菌中的融合表达

嗜水气单胞菌丝氨酸蛋白酶和溶血素是该菌重要的致病因子与保护性抗原。致病性嗜水气单胞菌TPS-30株为江浙一带鱼类暴发病病原主要血清型O:9的代表株。研究利用PCR方法扩增嗜水气单胞菌TPS-30株的丝氨酸蛋白酶基因(Spe)和溶血素基因(Hly),将基因Spe和Hly通过柔性片段进行融合,并将融合片段插入pET32a的多克隆位点,构建成重组融合表达载体pET32a-Spe-Hly。将重组载体转化大肠杆菌BL21(DE3),经异丙醛-β-D-硫代半乳糖苷(IPTG)诱导表达,获得融合蛋白Spe-Hly。表达产物经SDS-PAGE检测,显示与预期大小约130kD相吻合的融合蛋白带。纯化融合蛋白并对鲫鱼进行免疫攻毒试验。结果表明,丝氨酸蛋白酶基因和溶血素基因融合表达载体构建成功,并成功获得了融合蛋白Spe-Hly,对鲫鱼的免疫保护率达81.4%。这为基因工程亚单位多价疫苗的开发提供基础。       

嗜水气单胞菌外膜蛋白W 基因的表达及其免疫原性分析

从患暴发性败血病的草鱼病灶处分离鉴定了嗜水气单胞菌(Aeromonas hydrophila)Wp3菌株。以其基因组DNA为模板扩增外膜蛋白W基因(OmpW),该基因全长为865 bp,开放式阅读框(ORF)为615 bp,与标准株ATCC7966的OmpW基因的同源性为99.8%。根据ORF序列设计引物扩增OmpW成熟肽编码序列并将其插入到表达载体pQE30中,转化大肠杆菌,经诱导可表达分子量为24.7 kD的带His标签的融合外膜蛋白His-W。用此融合蛋白免疫草鱼,所得草鱼血清经ELISA分析显示呈现阳性反应,说明重组蛋白能诱导产生抗体。采用实时荧光定量PCR分析草鱼头肾组织IgM基因表达水平的变化,结果显示免疫组IgM的表达量均明显高于空白组,其中低浓度免疫组(2μg/g)与空白对照组的差异显著(P<0.05),说明融合蛋白可使草鱼产生良好的免疫应答并上调抗体基因表达、产生高效抗体。保护性实验显示,不同免疫剂量均可使免疫组获得较高保护率(57%?86%)。结果显示,重组嗜水气单胞菌外膜蛋白W可作为草鱼嗜水气单胞菌基因工程亚单位疫苗。     

西伯利亚鲟致病性嗜水气单胞菌外膜蛋白及其抗原性分析

采用十二烷基肌氨酸钠(Sarkosyl)法提取西伯利亚鲟嗜水气单胞菌(Aeromonas hydrophila)外膜蛋白,电泳显示所提取的主要外膜蛋白分子量为26～120 kDa;为比较该菌株与气单胞菌菌属其他细菌外膜蛋白组分及抗原性异同,以致病性豚鼠气单胞菌(A.caviae)、温和气单胞菌(A.sobria)和无致病力的嗜水气单胞菌为对照,电泳图谱显示4种气单胞菌外膜蛋白的分子量主要集中在26～120 kDa之间;利用抗西伯利亚鲟嗜水气单胞菌血清的免疫印迹试验表明该菌株外膜蛋白中分子量为75 kDa、52 kDa、43 kDa、40 kDa、34 kDa、28 kDa的蛋白条带呈现阳性反应,其他3种气单胞菌外膜蛋白中均有与该抗血清反应的条带,且分子量为28 kDa、34 kDa的反应条带为4株菌共有;43 kDa与75 kDa反应条带为部分菌株共有.为进一步筛选和研究致病性气单胞菌的共同保护抗原提供参考.     

西伯利亚鲟源嗜水气单胞菌致病菌的分离及其全菌苗的免疫效果

从患细菌性败血症的西伯利亚鲟(Acipenser baerii)的体内分离到一株致病菌株X1,其对西伯利亚鲟的半数致死浓度(LC50)为5.62×105 cfu/ml,具有较强毒力;经ATB细菌鉴定仪生理生化鉴定和16SrDNA序列分析,菌株X1为嗜水气单胞菌(Aeromonas hydrophila);其系统发育分析表明,菌株X1与嗜水气单胞菌ATCC35654(登录号:X74676.1)的亲缘关系最近,其同源性为99%.用0.30%福尔马林灭活,将菌株X1制成灭活全菌苗,对西伯利亚鲟进行注射免疫.研究结果表明,嗜水气单胞菌X1全菌苗能够明显提高西伯利亚鲟的血清抗体水平及总蛋白、免疫球蛋白、溶菌酶含量,而且在嗜水气单胞菌X1全菌苗中加入弗氏不完全佐剂,有利于进一步增强西伯利亚鲟血清抗体水平及总蛋白、免疫球蛋白、溶菌酶含量.此外,嗜水气单胞菌X1全菌苗对西伯利亚鲟抗嗜水气单胞菌X1人工感染也具有较好的免疫保护作用,其对西伯利亚鲟的免疫保护率为50%,而且在嗜水气单胞菌X1全菌苗中加入弗氏不完全佐剂,嗜水气单胞菌X1全菌苗对西伯利亚鲟抗嗜水气单胞菌X1人工感染的免疫保护作用更好,其对西伯利亚鲟的免疫保护率为70%.因此,将嗜水气单胞菌X1全菌苗用于西伯利亚鲟细菌性败血症的防治具有广阔的发展前景.     

嗜水气单胞菌外膜囊泡组分及功能分析

嗜水气单胞菌是一种鱼类常见的致病菌,且每年养殖业因感染该菌所造成的损失不也计其数。据研究表明,细菌的外膜囊泡具有免疫保护功能,然而目前对嗜水气单胞菌OMVs组分及其功能的研究还鲜有报道。故本研究首次分离纯化得到嗜水气单胞菌分泌的OMVs,然后利用其免疫小鼠的血清进行抑菌实验,结果表明抗OMVs血清具有良好的抑菌效果。为了进一步了解嗜水气单胞菌的OMVs蛋白的特性,本研究通过利用蛋白质组学技术对其蛋白组分进行分析。经结果分析共鉴定到191个蛋白,包括外膜蛋白、脂蛋白、胞浆蛋白等;并涉及细菌氧化还原作用、跨膜转运与生物学合成等多种重要的生物学功能和过程。此外,还有一些如外膜蛋白Omp A等的毒力因子蛋白的发现,都为日后蛋白相关疫苗的研制提供了候选储备。通过本研究,我们更全面地了解嗜水气单胞菌外膜囊泡的生物学功能,不仅有助于筛选具有重要免疫保护性的蛋白,也为研制嗜水气单胞菌的相关疫苗奠定了研究基础。     

嗜水气单胞菌佐剂灭活苗免疫中华鳖抵抗嗜水气单胞菌的致死性感染

通过建立中华鳖浸泡感染模型评价中华鳖嗜水气单胞菌油乳剂灭活疫苗对中华鳖的免疫保护效力。在主动免疫保护试验中,疫苗免疫组中华鳖能产生较高的抗体水平,在使用10×LD50的嗜水气单胞菌T3株进行浸泡攻毒后,保护率为100%(10/10),生理盐水对照组中华鳖的存活率仅为30%(3/10)。在被动免疫保护试验中,疫苗腹腔免疫异育银鲫抗血清能80%(8/10)保护中华鳖抵抗10×LD50的T3株的腹腔接种的攻击,生理盐水对照组中华鳖的存活率为20%(2/10)。研究结果表明嗜水气单胞菌佐剂油乳剂灭活苗具有良好的免疫学原性,可有效预防由嗜水气单胞菌引起的中华鳖红底板和肠道败血症等疾病。     

引起鱼类暴发性流行病的嗜水气单胞菌的血清型、毒力及溶血性

对分离自暴发病鱼的33株嗜水气单胞菌株的血清型、毒力和溶血性进行了研究。结果表明:按O抗原不同,大部分菌株可分为TPS-30和PBJS-76两个血清型,这两个血清型菌株分布于浙江各地及南方其它省市,可能是构成暴发病流行嗜水气单胞的主要血清型;这些菌株对健康白鲫有很强致病力,LD_(50)小于10~6,有很强的产溶血素能力,但某些菌株的毒力与其溶血效价无直接联系。     

引起鱼类暴发性流行病的嗜水气单胞菌的血清型、毒力及溶血性

对分离自暴发病鱼的33株嗜水气单胞菌株的血清型、毒力和溶血性进行了研究。结果表明:按O抗原不同,大部分菌株可分为TPS-30和PBJS-76两个血清型,这两个血清型菌株分布于浙江各地及南方其它省市,可能是构成暴发病流行嗜水气单胞的主要血清型;这些菌株对健康白鲫有很强致病力,LD₅₀小于10⁶,有很强的产溶血素能力,但某些菌株的毒力与其溶血效价无直接联系。     

嗜水气单胞菌S蛋白的提纯及特性分析

电镜观察表明,嗜水气单胞菌J-1株具有S层结构,在菌体外层呈晶格样规则排列。菌体经酸性甘氨酸缓冲液处理,S层从菌体上脱落,离心上清液即为粗提S蛋白。进一步经Sephadex G200凝胶层析和DEAE-纤维素离子交换层析纯化,获得的S蛋白呈单一多肽,分子量为51500。氨基酸组分分析结果表明,S蛋白含有天门冬氨酸等15种氨基酸,其中丙氨酸等疏水性氨基酸占36.8％。生物学活性显示,S蛋白对Vero细胞有轻微的细胞毒性,但没有溶血性,对鲫鱼和小鼠也无致死作用。用自制的嗜水气单胞菌J-1株S蛋白抗血清PM及PR和国外提供的嗜水气单胞菌TF7株S蛋白抗血清PF1分别作免疫转印和间接ELISA,检测来源于不同地区和不同动物种类的20株嗜水气单胞菌的S蛋白。结果表明,S蛋白的抗原性存在着菌株间的差异。另外,某些菌株不具有S层。     

鸭疫里默氏杆菌外膜蛋白生物学特性研究

血清2型鸭疫里默氏杆菌强毒菌株体外传200代获得了无毒力无免疫原性菌株,采用超声波裂解和超速离心法提取二株菌的外膜蛋白, 以比较分析鸭疫里默氏杆菌外膜蛋白的生物学特性。电镜观察细菌超微结构显示传代菌株外膜膜密度降低, 外膜泡的数量明显减少, 细胞质不均匀、内有空泡产生;免疫印迹结果表明二株菌的外膜蛋白免疫原性多肽存在明显区别;原代菌株的外膜蛋白仅与2型RA抗体出现特异性凝集, 而传代菌株的外膜蛋白与 1、2、10与11型RA抗体均出现凝集;二株菌的外膜蛋白均可诱导雏鸭产生抗体, 但原代菌株外膜蛋白诱导雏鸭产生抗体滴度显著高于200代次菌株;原代菌株外膜蛋白免疫鸭对同源RA菌株的攻击可产生100%的免疫保护, 而传代菌株外膜蛋白免疫鸭对同源RA菌株的攻击不产生免疫保护。序列分析显示两者的外膜蛋白A同源性达到99.9%。结果表明强毒菌株的外膜蛋白为良好的亚单位疫苗候选, 体外连续传代对RA外膜蛋白生物学特性影响显著。     

携带新城疫病毒DNA疫苗的鼠伤寒沙门氏菌及其安全性与免疫效力

根据GenBank中发表的新城疫病毒(NDV)融合蛋白(F)基因序列,设计一对引物,通过RTPCR扩增出鹅源新城疫病毒分离株JS5F基因,测序确认后,将其克隆入真核表达载体pVAX1,获得重组真核表达质粒pVAX1F。将pVAX1F转化减毒鼠伤寒沙门氏菌SL7207,构建成携带DNA疫苗的重组沙门氏菌SL7207(pVAX1F)。重组菌以不同剂量口服免疫1日龄雏鸡,结果表明,细菌对雏鸡具有良好的安全性,且不影响鸡的增重。将SL7207(pVAX1F)分别以108CFU和109CFU的剂量3次口服免疫1日龄商品代伊莎褐蛋鸡,抗体检测结果显示,在三免后1周,SL7207(pVAX1F)109CFU剂量组的血清抗体效价与空载体组之间存在显著性差异(p<0.05)。重组菌两个剂量组在首免后2周开始出现粘膜抗体,并于二免后2周和3周达到较高水平。免疫保护试验结果显示,SL7207(pVAX1F)109CFU剂量组的保护率为77.27%,与空载体组之间存在显著性差异(p<0.05)。     

嗜水产气单胞菌诱导的草鱼免疫球蛋白分析

取草鱼经嗜水产气单胞菌疫苗免疫,获免疫血清分两组,一组样品经饮和硫酸铵分级沉淀,秀析和电泳分析,另一组经Sephadex G-200柱层析分离及电泳分析,各分离样品经特异性集活性测定,发现沉淀分离组样品中抗体凝集活性最强的主要为35％饱和硫酸铵沉淀的组分,而柱层析分离组样品的凝集抗体主要集中在第一个洗脱蜂里。在电泳图谱中,各免疫组均比对照组增加了一条大分子B带,分子量为309kD左右,后者经变性电泳分离表现为两条区带,相对分子量分别为52kD和26KD。因而推测它们是单体IgG解离的重链和经链,而聚集在B带的是IgG的聚合形式IgM。     

Effectiveness of bivalent vaccines against Aeromonas hydrophila and Lactococcus garvieae infections in rainbow trout Oncorhynchus mykiss (Walbaum)

Lactococcus garvieae and Aeromonas hydrophila are bacterial pathogens affecting salmonids and other fish species and cause of heavy losses in aquaculture. Diseases caused by these bacteria can be controlled satisfactory by immunization using monovalent vaccines. In this study, the protective efficacy of two bivalent vaccines against L. garvieae and A. hydrophila was evaluated in rainbow trout (Oncorhynchus mykiss). Bivalent formulations, containing formalin-inactivated bacteria, were prepared as an aqueous bacterin and as an adjuvanted vaccine using montanide ISA-763. Protection against L. garvieae and A. hydrophila was tested at day 30 and 90 post-vaccination. High levels of protection were achieved for the aqueous and adjuvanted bivalent vaccines against L. garvieae (RPS of 100% and 95.3%) and A. hydrophila (RPS of 100% and 95.3%) at day 30 post-vaccination. Significant differences (p < 0.05) were found between the RPS at days 30 and 90 post-immunization with a decrease in the protection levels for the aqueous bivalent vaccine against L. garvieae (RPS 76.2%) and A. hydrophila (RPS 85%), but not for the adjuvanted vaccine (RPS of 90% against L. garvieae and 95% against A. hydrophila). In addition, high antibody levels were observed in the vaccinated fish at day 15 post-immunization using both vaccines. Our results demonstrate that these bivalent vaccines can effectively protect rainbow trout against L. garvieae and A. hydrophila and could offer an appropriate strategy to prevent these infections in rainbow trout farms.     

Pathogenicity of live bacteria and extracellular products of motile Aeromonas isolated from eels

The pathogenic activities in vitro and in vivo of live bacteria and extracellular products (ECP) of 24 motile Aeromonas strains were investigated. Most Aer. hydrophila and Aer. jandaei isolates were pathogenic for eels (LD₅₀ 10^5·4-10^7·6 cfu fish^-1) but no Aer. sobria , Aer. caviae and Aer. allosaccharophila caused mortality in eels at doses of > 10^8·4 cfu fish^-1. Of these Aeromonas strains, Aer. hydrophila and Aer. jandaei in particular produced elastases and haemolysins against fish erythrocytes. ECP from Aer. hydrophila and Aer. jandaei caused degenerative changes in fish cell lines and were strongly toxic for eels (LD⁵⁰ 1·0–3·2 μg (g fish)^-1) reproducing the symptoms associated with natural disease. ECP from non-pathogenic species were inactive on fish cell lines as well as being poorly lethal for eels (LD⁵⁰ > 9·2 μg (g fish)^-1). All these biological activities of Aeromonas ECP were lost after heat treatment. These findings indicate differences between pathogenic and non-pathogenic Aeromonas species with respect to the expression of virulence factors, and show that elastases, haemolysins and exotoxins play a leading role in the pathogenicity of motile Aeromonas for eels.     

Secretion of haemolysins and proteases by Aeromonas hydrophila EO63: separation and characterization of the serine protease (caseinase) and the metalloprotease (elastase)

AIMS: To determine the haemolysins and proteases excreted by the virulent strain EO63 of Aeromonas hydrophila grown in complex media and to then fractionate and characterize them, in particular those with elastolytic activity. METHODS AND RESULTS: The amount of haemolytic and proteolytic activity in EO63 culture supernatants was dependent on the culture media used. In all media, haemolysins appeared during the phase of active growth and haemolytic activity decreased quickly thereafter, as previously described for aerolysin. In contrast, proteases were mainly released during the stationary phase. Serine protease activity in EO63 culture supernatants was four times greater than that caused by metalloproteases. Two main proteases were partially purified from EO63 culture supernatants by isoelectrophoresis: a serine protease (68 kDa) active against casein; a mixture of different protein bands (60, 44 and 31 kDa) representing a thermostable metalloprotease active against elastin and casein. This metallo-elastase was also inhibited by dithiothreitol and showed a pH optimum of 8.0. Both exoenzymes were toxic for eels at LD50 doses of 1.1 and 3.5 microg (g fish)(-1), respectively. CONCLUSIONS: A serine caseinase and a metallo-elastase may play a role in the pathogenicity of EO63 for eels. These toxins are excreted in vitro by EO63 in the ratio of 4:1 during the stationary phase of growth. Strain EO63 also produced beta-haemolysins in vitro which could correspond to aerolysin. SIGNIFICANCE AND IMPACT OF THE STUDY: This is the first report on the purification of a metallo-elastase excreted by a wild-type A. hydrophila strain.     

卵形鲳鯵对刺激隐核虫的免疫应答和免疫保护研究

用刺激隐核虫(Cryptocaryon irritans)的幼虫对卵形鲳鯵(Trachinotus ovatus)进行腹腔注射和体表感染,然后每隔一周用阻动试验(Immobilization assay)检测免疫鱼的抗血清和皮肤培养液对刺激隐核虫幼虫的阻动效价,在第14周中,分别用亚致死剂量和致死剂量的刺激隐核虫幼虫对免疫鱼攻毒以检测所产生的免疫保护力。实验结果显示:两种免疫方法都能让卵形鲳鯵的血清和皮肤生成阻动刺激隐核虫幼虫的特异性抗体,并能使被免疫鱼获得明显的免疫保护,但是体表感染免疫组的血清和皮肤培养液的阻动效价都要比腹腔注射免疫组高,所获得的免疫保护力也更强。同时还发现,免疫鱼血清和皮肤培养液中的抗体存在明显的差异:两者的最初生成时间、达到峰值的时间、变化规律以及阻动效价等都不一致。因此,我们推测鱼类的系统免疫应答和皮肤黏膜免疫应答有可能是相互独立的,或者是不同步的。鱼类的体液免疫应答,特别是黏膜免疫应答对抵御刺激隐核虫的感染起了重要的作用,采用刺激隐核虫虫体疫苗可能成为预防海水鱼类白点病的一种选择。       

稳定携带H5亚型禽流感病毒候选DNA疫苗减毒沙门氏菌的构建及其免疫原性

采用PCR技术从重组质粒pVAX1-HA扩增出禽流感病毒JSGO(H5N1)株的血凝素(HA)基因,将其克隆入真核表达质粒pmcDNA3.1 中,获得重组表达质粒pmcDNA3.1-HA。通过电穿孔转化法将重组质粒转入减毒鼠伤寒沙门氏菌SL7207*,构建成功携带DNA疫苗的重组沙门氏菌SL7207*(pmcDNA3.1-HA)。经体内体外试验证实,重组质粒pmcDNA3.1-HA在沙门氏菌中的稳定性显著高于pcDNA3.1-HA。将重组菌SL7207*(pmcDNA3.1-HA)和SL7207*(pcDNA3.1-HA)分别以2×109CFU剂量两次口服免疫BALB/c小鼠,免疫小鼠可产生针对禽流感病毒HA蛋白的黏膜抗体。重组菌以5×109CFU剂量两次口服免疫试验鸡,免疫鸡的小肠样品中可测到针对禽流感病毒HA蛋白的黏膜抗体,且SL7207*(pmcDNA3.1-HA)免疫组的抗体效价高于SL7207*(pcDNA3.1-HA)免疫组。免疫保护试验结果显示,SL7207*(pmcDNA3.1-HA)和SL7207*(pcDNA3.1-HA)免疫组的免疫保护率均与空载体组之间存在显著性差异(P<0.05),且SL7207*(pmcDNA3.1-HA)免疫组的保护率较SL7207*(pcDNA3.1-HA)免疫组提高了22.6%,说明稳定携带H5亚型禽流感病毒DNA疫苗的减毒沙门氏菌具有良好的免疫原性和免疫保护性。     

Administration of yeast glucan enhances survival and some non-specific and specific immune parameters in carp (Cyprinus carpio) infected with Aeromonas hydrophila

Effects of beta-glucan administration on survival and immune modulations were studied in Cyprinus carpio against the bacterial pathogen, Aeromonas hydrophila. Beta-glucan was extracted from Saccharomyces cervisiae and purified. A virulent strain of the pathogen A. hydrophila was collected from infected fish. Different concentrations of beta-glucan were administered to test animals on day 1, 3 and 5 through different routes (intraperitoneal injection (ip), bathing and oral administration). Control and test animals were challenged by ip injection of LD50 concentration of A. hydrophila on day 7 and mortality was observed and Relative Percent Survival (RPS) was calculated. Intraperitoneal injection of 500 microg of glucan significantly enhanced the RPS; bathing and oral administration of glucan did not influence the RPS. On day 7, test animals injected with 100, 500 and 1000 microg of glucan had a significant increase in total blood leucocyte counts and an increase in the proportion of neutrophils and monocytes. Superoxide anion production by kidney macrophages was also elevated. RT-PCR and northern blot analysis of interleukin-1 mRNA showed elevated expression in kidney on day 7 in fish injected with glucan. Glucan had an adjuvant effect on antibody production as pretreatment by injection of 100-1000 microg glucan/fish resulted in the highest antibody titer against A. hydrophila following vaccination. Classical and alternative complement pathways were not affected by glucan administration by any of the three routes.     

稳定携带新城疫病毒DNA疫苗减毒沙门氏菌的构建及其免疫原性

采用PCR技术从重组质粒pVAX1-F中扩增出新城疫病毒JS5株的融合蛋白(F)基因,将其克隆入真核表达质粒pmcDNA3.1 中,获得重组表达质粒pmcDNA3.1-F.通过电穿孔转化法将重组质粒转入减毒鼠伤寒沙门氏菌SL7207,构建成功携带DNA疫苗的重组沙门氏菌SL7207(pmcDNA3.1-F).体内、体外试验结果表明,重组质粒pmcDNA3.1-F在沙门氏菌中的稳定性显著高于pcDNA3.1-F.将重组菌SL7207(pmcDNA3.1-F)和SL7207(pcDNA3.1-F)分别以1×109 CFU剂量两次口服免疫BALB/c小鼠,免疫小鼠可产生针对新城疫病毒F蛋白的血清抗体和黏膜抗体.重组菌以5×109 CFU剂量两次口服免疫4日龄SPF鸡,免疫鸡产生的针对新城疫病毒F蛋白的血清抗体和小肠黏膜抗体效价水平与空载体组之间存在显著性差异(P＜0.05).免疫保护试验结果显示,SL7207(pmcDNA3.1-F)和SL7207(pcDNA3.1-F)免疫组的免疫保护率均与空载体组之间存在显著性差异(P＜0.05),且SL7207(pmcDNA3.1-F)免疫组的保护率较SL7207(pcDNA3.1-F)免疫组提高了20.0%,说明稳定携带新城疫病毒DNA疫苗的减毒沙门氏菌具有良好的免疫原性和免疫保护性.     

Neem (Azadirachta indica) extract as an antibacterial agent against fish pathogenic bacteria

Aquaneem, an emulsified product prepared from the neem (A. indica) kernel was tested against four pathogenic bacteria of fish (i.e. Aeromonas hydrophila, Pseudomonas fluorescens, Escherichia coli and Myxobacteria spp.) to test its efficacy as an antibacterial agent. Growth inhibitory property of the product at 10, 15 and 20 ppm has been noticed and recorded. The percentage reduction of bacterial cell population was noted to be maximum on 9th day at 20 ppm concentration (i.e. 70.14%, 74.15% and 61.75% for A. hydrophila, P. fluorescens and E. coli respectively) with the only exception of myxobacteria which showed maximum reduction percentage (63.90%) on 15th day. Among all the bacteria tested A. hydrophila, P. fluorescens and Myxobacteria spp. exhibited maximum sensitivity to Aquaneem in terms of percentage reduction of bacterial cell population in comparison to E. coli.